Application of pharmacogenomics in cancer
This course provides an overview of somatic and germline Pharmacogenetics in cancer patients. It illustrates pharmacogenomic-based diagnostics in oncology and pharmacogenomic factors that are associated with inter-individual differences in toxicity and therapeutic response of many chemotherapy agents. The course introduces different types of biomarkers that are associated with the response and toxicities of chemotherapeutics. Patient cases and clinical recommendations are also presented.
Teaching methods
• Lectures
• E-Lab
- Course CodeOPPM 302
- ModuleModule 3
- Credit Hours8ECTS/3EG/3LB
- Describe the impact of pharmacogenomics on optimizing cancer chemotherapy and reducing adverse drug effects and drug toxicities to improve therapeutic outcomes in cancer patients.
- Apply pharmacogenomics concepts to cancer therapy to solve relevant problems in healthcare.
- Discuss case studies reporting clinical consequences of pharmacogenomics chemotherapeutic agents efficacy.
- Evaluate relevant literature with respect to pharmacogenomics in genetic testing for inherited cancer susceptibility and its impact on patient care.
- Encourage the healthcare team collaboration regarding the dissemination of Pharmacogenomics concepts, patient education, and collaboration between healthcare providers.